Inactive Instrument

News PROTEK

Equities

PRTK

RU000A0JQU47

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Public Joint-Stock Company Protek Reports Earnings Results for the Full Year Ended December 31, 2019	30/20/30	CI
Protek : Board of Directors’ Chair Vadim Yakunin and Protek’s President Vadim Muzyaev Awarded with Healthcare Excellence Badge	02/19/02	PU
Protek : Chair of Protek Group’s Board of Directors Vadim Yakunin Awarded with Badge of Venerable Sergius of Radonezh	11/19/11	PU
Protek : is among the top 100 best employers of Russia	28/19/28	PU
Protek : Rigla Led the Rankings of the most Influential Pharmacy Chains in 2018	22/19/22	PU
Protek : CV PROTEK Once Again Led the Rankings of the Pharmaceutical Distributors for 2018	22/19/22	PU
Protek : Executives Ranked in the TOP 1000 Russian Managers Again	28/18/28	PU
Protek Group Reports Consolidated Earnings Results for the First Half of 2018	28/18/28	CI
Protek : Rigla is atop the rating of pharmacy chains for 2017	09/18/09	PU
JSC Rafarma announced that it has received funding from Public Joint-Stock Company PROTEK	04/17/04	CI
Protek OOO acquired an additional 0.19% stake in Public Joint-Stock Company PROTEK.	27/17/27	CI
Protek LLC acquired an additional 0.0522% stake in Public Joint-Stock Company PROTEK.	23/17/23	CI
PROTEK Group Announces Unaudited Consolidated Revenue Results for Third Quarter and Nine Months Ended September 30, 2017	26/17/26	CI
Protek : is among ТОP-3 leaders in wholesale turnover	04/17/04	PU
Protek : Rigla headed the rating TOP-200 Pharmacy Chains for the Ist half-year 2017	04/17/04	PU
Protek : CV PROTEK became the leader of pharmaceutical distributors rating in the 1 half-year 2017	25/17/25	PU
The Protek Reports Consolidated Earnings Results for the First Half of Fiscal Year 2017	25/17/25	CI
Protek : Rigla again leads the rating of pharmacy chains	25/17/25	PU
PROTEK Group Reports Audited Consolidated Earnings Results for the Year 2016	20/17/20	CI
Open Joint Stock Company Protek completed the acquisition of Joint Stock Company Rafarma from Rafarma Pharmaceuticals, Inc..	18/17/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer